Tagged with

Medicover You became president of the board at Medicover in Poland only a while ago and previously your previous experience was in high-profile management but not in healthcare. Do you now feel increased pressure being involved in a business where decisions take on a more ethical dimension? From a process perspective…

Roche Products (India) Pvt. Ltd. There is no doubt that India has become a country of rising opportunities. Can you first elaborate how important India has become for the Group worldwide? India has become very important, mainly because of the rising middle class population in the country. One of the problems with India however, is…

Roche is the leading company in the ONLS (high-technology reimbursement) segment of the prescription drug market, and also the top oncology company in Russia. As the General Manager of the Company since 2005, can you explain how you achieved this leading position? It was quite a natural process once we…

MSD Russia You have been in Russia now for a bit less than a year, having come from the former Schering-Plough’s Hungary office to run the Russian MSD affiliate. In our conversation prior to the interview, you mentioned that there has been a bit of a transition and adjustment period. How is…

Info Kinetics 2011 marks the 10th anniversary of the company. Over that time you’ve enjoyed notable success including being the first Asian CRO to attain OECD GLP accreditation. Talk us through your proudest achievements? First of all we want to make clear that Info Kinetics was never a local company. It has…

IMS ‘lives and breathes the pharma industry’ and it is stimulating to come from other forms of consultancy to IMS. You have worked in various businesses. What motivated you to join IMS and focus on the pharma industry? My decision was the outcome of my experiences in different sectors. I…

After an international career of 15 years with Eli Lilly, you are quite new to both the country as well as the company. Looking back at these first 7 months, how did you experience this possibly challenging transition? First of all, the cultures between the two organizations are not that…

Binnopharm Binnopharm was established in 2006, with 100% of charter capital coming from holding company JSFC Sistema. What was the vision behind the creation of Binnopharm? The company was indeed established in 2006, but operations did not actually begin until 2009. JSFC Sistema is a company that often works in markets…

Nycomed Russia-CIS Nycomed is currently constructing a Greenfield plant in the Yaroslavl region, at an investment of 75-80Mn EUR. Last time we met in 2006, many foreign companies viewed local production as strategically and economically unattractive. What have been the evolutions in the market that have made construction of a Russian facility…

Biocon If we look back at the conditions under which you founded Biocon in 1978, we see a young woman with a seed capital of only Rs. 10,000 in a garage in an infrastructure deficient Bangalore. Both India and Biocon have come a long way since then. How different is the…

Lonza India Pvt. Ltd You have already publicly announced that, despite being late in India, Lonza has been increasingly looking into expanding in the Indian market. First of all, what do you think sparked the increasing interest in this market? The driving factor was the fact that the Indian consumer market has been increasing.…

Boehringer Ingelheim India Pvt. Ltd. Before moving into the company’s strategy, can you give our readers an idea of what role Boehringer Ingelheim India plays within the Group’s worldwide operations? Within the Boehringer Ingelheim Group, there are the mature and emerging markets for the prescription medicines. Within this structure, India falls into the emerging markets…